Mersana Therapeutics
MRSN
#9148
Rank
C$0.12 B
Marketcap
$1.04
Share price
-44.62%
Change (1 day)
-74.36%
Change (1 year)

Revenue for Mersana Therapeutics (MRSN)

Revenue in 2024 (TTM): C$46.87 Million

According to Mersana Therapeutics's latest financial reports the company's current revenue (TTM ) is C$50.27 Million. In 2023 the company made a revenue of C$48.88 Million an increase over the revenue in the year 2022 that were of C$36.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mersana Therapeutics from 2016 to 2024

2017201820192020202120222023$10M$20M$30M$40M$50M$60M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) C$46.87 M-4.12%
2023 C$48.88 M35.52%
2022 C$36.06 M64222.53%
2021 C$0.05 M-94.7%
2020 C$1.05 M-98.08%
2019 C$55.01 M281.19%
2018 C$14.43 M-34.57%
2017 C$22.05 M-34.79%
2016 C$33.82 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA